Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis.

Conclusion: Our results indicate that the study facial cream represents an option to consider when dealing with mild-to-moderate SD, being effective, well-tolerated, and free of significant side effects, as confirmed by clinical and instrumental evaluation. PMID: 30774406 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30774406?dopt=Abstract

Source: Clinical, Cosmetic and Investigational Dermatology - February 19, 2019 Category: Dermatology Tags: Clin Cosmet Investig Dermatol Source Type: research